Colloidal silver has antimicrobial properties, but it’s also a toxic heavy metal. Find out if silver is a safe and effective treatment for Lyme disease.
Question: Does colloidal silver treat Lyme disease?
The answer is yes, colloidal silver does have antimicrobial properties. The question is, do we want to use it on humans?
There’s no doubt that silver has antimicrobial properties that have been well-documented for a long time. But so does mercury. All heavy metals have some antimicrobial-type properties. We have people that are doing everything they can to get mercury and heavy metals out of their bodies, and yet they’re dumping silver into their bodies to try to kill Lyme disease bacteria.
It really doesn’t make that much sense to me. Silver is not as toxic as mercury, but it still does have some toxicity, and it’s really hard for your body to remove it. If you use it for a long time, you are going to accumulate silver in your tissues.
Back when I was struggling with Lyme disease, I actually tried colloidal silver. I took it for a short period of time, and compared to other things that I used — predominantly herbs — it didn’t seem to have quite the punch that the herbs did. One herb alone wasn’t enough, but when I took combinations of herbs, that seemed to be superior to the silver.
So, for me, herbs were really a much better choice. I still have some reservations about silver, and I think that when you look at the spectrum of things that you can use for Lyme disease, herbs rank right up there at the top. Silver is quite a bit further down the list.
When you look at overcoming Lyme disease, it’s not a week or day type of thing. You have to take the antimicrobial for months and years. It’s about long-term suppression, and the advantage of herbs is you can do that long-term suppression without toxicity to your body.
If you’re looking at treating Lyme disease with silver, remember, you’re not talking about days or weeks, you’re talking about months and years of using it, which could potentially increase the toxicity. I would put my money on the herbs as being the better therapy out there.
Dr. Rawls is a physician who overcame Lyme disease through natural herbal therapy. You can learn more about Lyme disease in Dr. Rawls’ new best selling book, Unlocking Lyme.
You can also learn about Dr. Rawls’ personal journey in overcoming Lyme disease and fibromyalgia in his popular blog post, My Chronic Lyme Journey.
_____________________
**Comment**
The important point is that treatment often lasts from months to years, often requiring numerous types of treatments. Be open minded because what works for one, often doesn’t work for another.
While my family has used a high potency colloidal silver spray for sore throats for a very short duration (a few days) with success, from my experience with other patients, I do not believe this is strong enough for Lyme/MSIDS nor do I think long term usage to be wise due to accumulating metal. Dr. Rawls makes another astute point – patients often spend thousands of dollars eliminating toxic metals from the body. Why would you purposely add more?
Treatment is long. Treatment is painful. Treatment is expensive. Treatment is controversial.
This is not to say that certain forms/combinations won’t be found to work in the future. Research is ongoing.
I also know patients who either live in areas without Lyme literate doctors OR they can not afford to see one. Necessity sometimes corners you to have to consider treatment options that are less than optimal. While unfortunate, people often have to use what’s available. I rejoice when anyone improves – on anything! Patients have often improved on things I never would have believed worked. The important thing is you look at all your options and work with your practitioner, honestly keeping track of symptoms and what works and what doesn’t.
China, George Soros and Bill Gates plot to dictate science and worldwide drug distribution, while exploiting U.S. hospitals and taking advantage of Americans
(Natural News) Public health officials under a Trump administration or under a potential Biden administration will never offer a scientific strategy to strengthen human immunity. This is because fearful, weak and obedient populations are easy to control and profit from, and pharmaceutical companies own the media narrative and every politician’s reputation and economic figures. The proof is obvious. The federal government dumped over $10 billion into pharmaceutical companies in 2020, looting public funds to develop only drugs and vaccines — which populations are being psychologically trained to anticipate and to depend upon.
One of the companies that enjoyed free taxpayer money was Gilead. The Department of Defense paid Gilead $34.5 million to develop remdesivir, a potential treatment for Ebola virus. The National Institutes of Health awarded Gilead $6 million taxpayer dollars to speed up its development and sunk another $30 million of taxpayer dollars into clinical trials to observe Remdesivir’s effect on covid-19 patients.
Gilead loots American taxpayers and moves business to China
The U.S. FDA recently granted Remdesivir the agency’s coveted “orphan drug status” so the drug could be fast tracked through the FDA’s drug review process – despite shoddy data on its safety and effectiveness. As soon as Gilead got what they wanted, the company took remdesivir out of the U.S. and partnered with China to exploit world populations through a sophisticated pyramid scheme. More specifically, Gilead partnered with a drug facility in China owned by George Soros.
After the swift move to China, Gilead’s stock price surged 20 percent in Shanghai. BrightGene Bio-Medical Technology, a Suzhou based company, is using new technology to synthesize and distribute Remdesivir to the world. Chinese researchers from the Wuhan Institute of Virology filed an application to patent Remdesivir. China will now have control over the world’s template covid-19 treatment plan, ultimately to rip off Americans for a drug that American taxpayers primarily funded in the first place. Gilead has already partnered with Chinese Health Authorities to conduct new clinical trials for Remdesivir. Why is an American company working with China to dominate the drug market?
George Soros is in on the deal. Gilead is partnered with Wuxi Pharmaceuticals, a molecule drug discovery and research facility owned by George Soros. This astonishing connection was revealed in George Soro’s own financial portfolio, which lists the partnering facility at 666 Gaoxin Road, East Lake High Tech Development Zone, Wuhan, China. This is the same Chinese city where the outbreak began. The Wuhan Institute of Virology was the lab funded by the US National Institutes of Health to study gain-of-function properties of coronaviruses.
China not only has the ability to manufacture bio-weapons and understand how they infect humans, but they also have the patent on the treatment that they can now use to control the rest of the world.
Gilead, Bill Gates, and George Soros will take advantage of Americans by utilizing a drug purchasing ring called UNITAID
Gilead is a well-connected company, involved in a drug purchasing ring called UNITAID. This worldwide drug distributor oversees a “patent pool” that allows pharmaceutical companies to share their drug patents with other companies. The original patent holder receives royalties when they allow other companies to produce generic drugs derived from their patented drug. This allows the original patent holder to distribute their drug to both rich and poor nations, while capitalizing on both. The original drug, Remdesivir, is sold at a high price to the U.S., and provided cheaply to African countries, all while the original Chinese patent holder profits immensely. China is now included in UNITAID’s “drug pool” – giving the communist country the cheapest prices on the new drug. America is not included, and U.S. patients will pay over $3,000 for this standardized treatment.
This UNITAID drug distribution network was derived from the United Nation’s Global compact. UNITAID is financially supported by WHO (Bill and Melinda Gates), UNAIDS, Global Fund, Roll Back Malaria Partnership, and Mr. George Soros himself. Soros has not only set up a facility to profit from Remdesivir, but he uses those profits to set up the system that enables him to take advantage of the U.S. in a sophisticated price gouging scheme, while still profiting off the drug’s distribution around the world through UNITAID’s drug pool. This all came to fruition first and foremost after Gilead claimed a monopoly on coronavirus treatment science while using taxpayer funds and the U.S. FDA for fast-track approval to push their questionable drug forward.
This is why people around the world are being taught to live in fear of the virus instead of taking personal action to strengthen their immune system.
George Soros, Bill Gates, and the drug and vaccine companies are strategizing to profit from and dominate the world population for years to come, while specifically targeting U.S. hospital systems and Americans.
Going back to 1997, Donald Rumsfeld chaired the Board of Directors at Gilead and after 2001 he held share packages valued at $5-25 Million. Gilead originally developed Tamiflu.George P Shultz, US Secretary of State also was on the board. He sold stocks at a value of more than $7 million. CA governor’s Pete Wilson’s wife also sat on the board.
“‘I don’t know of any biotech company that’s’ so politically well-connected [as Gilead],‘ Andrew McDonald, of the analyst firm Think Equity Partners, told Fortune.” (Source: “Virus Mania, How the Medical Industry Continually Invents Epidemics Making Billion Dollar Profits At Our Expense”)
Approximately $70 million in U.S. taxpayer funding began Gilead’s partnership with the U.S. Army, Centers for Disease Control and Prevention (CDC) and National Institutes of Health (NIH) to develop remdesivir. Initially for treating Ebola, it failed to show benefit and was shelved. If remdesivir is used to treat COVID-19, Gilead shareholders, not the taxpayers, will profit.
Dr Vega, MD gives info on vit C in COVID-19. He is a radiation oncologist, board certified. Interesting (8.00 min), he plans to treat in a clinical study students in high school with oral vit C, so he can prove schools can stay open with vit C.
He informs about studies and treatment with high dose intravenous vitamin C and oral vit C in COVID-19 and other virus-related diseases.
Vitamin D Might Just Save You From Getting COVID-19
Sept. 12, 2020
In the video, Taha Meli Arvas explains that a study conducted at the University of Chicago and published this week in the Journal of the American Medical Association claims that vitamin D deficiency may have been factor in the infections of COVID-19 patients. In fact, patients that had a vitamin D deficiency or those whose deficiency were not treated were almost twice as likely to test positive for the coronavirus relative to those that had enough vitamin D. Why is this a major breakthrough? This means that those that are already vitamin D deficient, and this is a majority of the population by the way, may need only to take vitamin D supplements to boost their immune system to prevent from getting the coronavirus and successfully battle it if they’ve already been infected.
Connecting the dots is easy. The government is spending over $10 billion on its Operation Warp Speed to produce a vaccine that will be shielded from liability.
A rushed COVID-19 vaccine will not go through full safety trials, yet the FDA will probably issue an Emergency Use Authorization (EUA) to approve a vaccine. To issue an EUA, there must be “no adequate, approved, and available alternative.”In other words, HCQ or another effective treatment is a threat to a vaccine; if hydroxychloroquine is effective, there can be no fast-tracked vaccine.
Vitamins and other successful treatments are a threat to our government.
According to Dr. Thomas Frieden, former director of the U.S. Centers for Disease Control and Prevention, COVID- 19 is now the third leading cause of death in the U.S., killing more Americans than “accidents, injuries, lung disease, diabetes, Alzheimer’s and many, many other causes.”1,2
This claim is said to be based on data from Johns Hopkins University which, at the time Frieden made that statement in August 2020, reported that about 170,000 of the 5.4 million Americans who had tested positive had died.3 At the time of this writing, Johns Hopkins reports4 the U.S. has recorded 7,916,099 positive tests and 216,872 COVID-19-related deaths.
Medical Errors Dwarf COVID-19 Concerns
There are many reasons not to panic over Frieden’s claim. I’ll review mortality statistics in just a moment but, first, I want to highlight a leading cause of death that continues to be swept under the proverbial rug, namely medical errors, because medical errors also play a role in the death toll attributed to COVID-19.
In 2016, a Johns Hopkins study5,6 found more than 250,000 Americans die each year from preventable medical errors, effectively making modern medicine the third leading cause of death in the U.S. I reported these findings in “Medical Errors: Still the Third Leading Cause of Death.”
Other research7 has estimated the number of Americans dying from medical mistakes may actually be as high as 440,000. The reason for the discrepancy in the numbers is because medical errors are rarely noted on death certificates, and death certificates are what the CDC relies on to compile its death statistics.
As a result, the severity of the problem goes unnoticed. Either way, whether it’s 250,000 or 440,000, medical errors still claim more lives than COVID-19 has, and it does so on an annual basis.
Medical Errors Responsible for Most COVID-19 Deaths
We also need to remember that a large portion of those who died from COVID-19 were in fact victims of medical errors. As I reported in “Nurse on theFrontlines of COVID-19 Shares Her Experience” and “Frontline Nurse Speaks OutAbout Lethal Protocols,” Elmhurst Hospital Center in Queens, New York — which was “the epicenter of the epicenter” of the COVID-19 pandemic in the U.S. — grossly mistreated COVID-19 patients, causing their death.8
According to Army trained nurse, Erin Olszewski, who worked at Elmhurst during the height of the pandemic, hospital administrators and doctors made a long list of errors, most egregious of which was to place all COVID-19 patients, including those merely suspected of having COVID-19, on mechanical ventilation rather than less invasive oxygen administration.
During her time there, most patients who entered the hospital wound up being treated for COVID-19, whether they tested positive or not, and only one patient survived. The hospital also failed to segregate COVID -positive and COVID -negative patients, thereby ensuring maximum spread of the disease among noninfected patients coming in with other health problems.
By ventilating COVID-19-negative patients, the hospital artificially inflated the case load and death rate. Disturbingly, financial incentives appear to have been at play. According to Olszewski, the hospital received $29,000 extra for a COVID-19 patient receiving ventilation, over and above other treatments. In August 2020, CDC director Robert Redfield admitted that hospital incentives likely elevated hospitalization rates and death toll statistics around the country.
Irresponsible State Leadership Caused Many COVID-19 Deaths
Another major error that drove up the death toll was state leadership’s decision to place infected patients into nursing homes, against federal guidelines.9 According to an analysis10,11 by the Foundation for Research on Equal Opportunity, which included data reported by May 22, 2020, an average of 42% of all COVID-19 deaths in the U.S. had occurred in nursing homes, assisted living and other long-term care facilities.
This is extraordinary, considering this group accounts for just 0.62% of the population. By and large, nursing homes are ill equipped to care for COVID-19 infected patients.12 While they’re set up to care for elderly patients — whether they are generally healthy or have chronic health problems — these facilities are rarely equipped to quarantine and care for people with highly infectious disease.
It’s logical to assume that comingling infected patients with noninfected ones in a nursing home would result in exaggerated death rates, as the elderly are far more prone to die from any infection, including the common cold. We also learned, early on, that the elderly were disproportionately vulnerable to severe SARS-CoV-2 infection.
Yet ordering infected patients into nursing homes with the most vulnerable population of all is exactly what several Democrat governors decided to do, including New York Gov. Andrew Cuomo,13 Pennsylvania Gov. Tom Wolf, New Jersey Gov. Phil Murphy, Michigan Gov. Gretchen Whitmer and California Gov. Gavin Newsom.
ProPublica published an investigation14 June 16, 2020, comparing a New York nursing home that followed Cuomo’s misguided order with one that refused, opting to follow the federal guidelines instead. The difference was stark.
By June 18, the Diamond Hill nursing home — which followed Cuomo’s directive — had lost 18 residents to COVID-19, thanks to lack of isolation and inadequate infection control. Half the staff (about 50 people) and 58 patients were infected and fell ill.
In comparison, Van Rensselaer Manor, a 320-bed nursing home located in the same county as Diamond Hill, which refused to follow the state’s directive and did not admit any patient suspected of having COVID-19, did not have a single COVID-19 death. A similar trend has been observed in other areas.
If it weren’t for systematic medical mistreatment at certain hospitals and incomprehensible decision-making by a handful of state governors, the COVID-19 death toll may well have been negligible.
We should also remember that a) the vast majority of people died with SARS-CoV-2 infection, not from it, and b) medical treatments showing significantpromise have been savagely censored and even barred from use based on falsified and seriously flawed studies. According to groundbreaking data15 released by the CDC August 26, 2020, only 6% of the total COVID -19-related deaths in the U.S. had COVID-19 listed as the sole cause of death on the death certificate. Six percent of 201,141 (the total death toll reported by the CDC as of October 14, 2020) is 12,068. In other words, SARS-CoV-2 infection was directly responsible for just over 12,000 deaths of otherwise healthy individuals. The remaining 94% had an average of 2.6 health conditions that contributed to their deaths. When you add all of these factors together — the wanton mismanagement of the infection in hotspots such as New York, the decision to send infected patients into nursing homes, the fact that few healthy people died from the infection and that potential medical treatments have been and still are actively suppressed — it kind of starts to look like a manufactured crisis.
Infection Fatality on Par With the Flu
While Frieden is now stoking fears by claiming COVID-19 is the third leading cause of death, and Scientific American is calling the claim that its fatality is on par with the flu “fake news,”16 I would call your attention to research looking at the fatality ratio for the average person, excluding those residing in nursing homes and other long-term care facilities.
The overall noninstitutionalized infection fatality ratio [for COVID-19] was 0.26% … Persons younger than 40 years had an infection fatality ratio of 0.01%; those aged 60 or older had an infection fatality ratio of 1.71%. ~ Annals of Internal Medicine September 2, 2020
The September 2, 2020, article17 in Annals of Internal Medicine points out that, because many who test positive for SARS-CoV-2 remain asymptomatic it’s very difficult to estimate the true infection rate, and when calculating mortality rates based on confirmed “cases” (meaning positive tests) you end up overestimating the infection fatality ratio. As explained by the authors:18
“To calculate a true infection fatality ratio, population prevalence data are needed from large geographic areas where reliable death data also exist … We combined prevalence estimates from a statewide random sample with Indiana vital statistics data of confirmed COVID-19 deaths.In brief, our stratified random sample consisted of state residents aged 12 years and older. Known decedents and incarcerated persons were excluded. Because nursing homes were limiting residents’ ability to leave and re-enter the facilities, their participation was unlikely.
Participants were tested from 25 April to 29 April 2020 for active viral infection and SARS-CoV-2 antibodies, which would indicate prior infection … We calculated the IFR by age, race, sex, and ethnicity on the basis of the cumulative number of confirmed COVID-19 deaths as of 29 April 2020, divided by the number of infections.
Although nursing home residents were not tested, they represented 54.9% of Indiana’s deaths. Thus, we excluded nursing home residents from all calculations (that is, deaths and infections).To account for all infections, we added the number of patients hospitalized with COVID-19 during the testing period and noninstitutionalized COVID-19 deaths into the denominator …
Our random-sample study estimated 187,802 cumulative infections, to which 180 hospitalizations were added. The average age among all COVID-19 decedents was 76.9 years. The overall noninstitutionalized infection fatality ratio was 0.26% … Persons younger than 40 years had an infection fatality ratio of 0.01%; those aged 60 or older had an infection fatality ratio of 1.71%.”
The estimated infection fatality rate for seasonal influenza listed in this paper is 0.8%. Other sources put it a little higher. In either case, according to this paper the only people for whom SARS-CoV-2 infection is more dangerous than influenza are those over the age of 60.
All others have a lower risk of dying from COVID -19 than they have of dying from the flu. Put another way, if you’re under the age of 60, your chance of dying from the flu is greater than your chance of dying from COVID-19.
White House coronavirus task force coordinator Dr. Deborah Birx also confirmed this far lower than typically reported mortality rate when she, in mid-August 2020, stated that it “becomes more and more difficult” to get people to comply with mask rules “when people start to realize that 99% of us are going to be fine.”19
In addition to COVID-19 having a lethality on par with the flu (again for the average person under the age of 60): • Data20,21 show the overall all-cause mortality has remained steady during 2020 and doesn’t veer from the norm. In other words, COVID-19 has not killed off more of the population than would have died in any given year anyway •
Several studies22,23,24,25,26,27,28,29 also suggest immunity against SARS-CoV-2 infection is far more widespread than anyone imagined •The threshold for herd immunity appears to be far lower than previously estimated30,31,32,33,34
As reported by British Sky News,35 October 7, 2020, respected scientists are now calling for a herd immunity approach to the pandemic, meaning governments should allow people who are not at significant risk of serious COVID-19 illness to go back to normal life. As of October 18, 2020, The Great Barrington Declaration36 had been signed by 10,601 medical and public health scientists and 29,296 medical practitioners.37